The vaccine has been able to create several highly immunogenic thermotolerant versions and has generated several neutralizing antibodies to act against some of the new variants.
Mysurean heads IISc s Oxygen Concentrator team starofmysore.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from starofmysore.com Daily Mail and Mail on Sunday newspapers.
Warm vaccine, Lukewarm response: IISc’s homegrown Covid-19 vaccine hits funding wall
SECTIONS
Share
Synopsis
The indigenous heat-stable vaccine, once cleared for use, will best suit India’s weather and could potentially revolutionise vaccine delivery in the fight against Covid-19.
Agencies
The team has yet to conduct process development as well as safety and toxicity study, which are required before progressing to clinical trials.
A team of researchers at the Indian Institute of Science (IISc) has been working to develop a homegrown vaccine for Covid-19 for the last one year.
The scientists have obtained promising results in animal trials with vaccine formulations that can generate antibodies to neutralise even some dangerous mutants of the virus.
The Covid-19 pandemic has not just battered the healthcare sector, but it has also resulted in financial crisis across sectors.Mynvax, a startup incubated by the Society of Innovation and Development (SID) at the Indian Institute of Science .
IISc’s vax has potential to fight Indian variants, but it has a funding problem
ByHemanth CSHemanth CS / Updated: May 3, 2021, 06:00 IST
It’s other key advantage: It can be stored at room temperature after freeze drying
With the chorus for more options for covid vaccines getting louder and louder, and foreign vaccines waiting for approval to be allowed in India, another local vaccine is under development. And this one is being developed in
Bengaluru.
A recombinant subunit vaccine for SARS-CoV-2 which is being developed by the
Indian Institute of Science (IISc), has over the last few months been able to create several highly immunogenic thermotolerant versions, said researchers associated with the project.